181 Results for "

5-lipoxygenase inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (181)

181 Results for "5-lipoxygenase inhibitor" in MCE Product Catalog:

757
757 Publications Verification
Cat. No.: HY-B0215
CAS No.: 616-91-1
Synonyms: N-Acetylcysteine; N-Acetyl-L-cysteine; NAC
Acetylcysteine (N-Acetylcysteine) is a mucolytic agent that can cross the blood-brain barrier, which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases. Acetylcysteine induces cell apoptosis. Acetylcysteine also has anti-influenza virus activities. In addition, Acetylcysteine ​​is the most stable form of cysteine ​​during drug delivery and can be used in disulfidptosis studies .
loading...
    loading...
112
112 Cited Publications
Cat. No.: HY-13419
CAS No.: 112648-68-7
Purity:  98.41%
U-73122 is a phospholipase C (PLC) and 5-LO (5-lipoxygenase) inhibitor with an IC50of 1-2.1 µM for PLC.
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-14164
CAS No.: 111406-87-2
Purity:  99.61%
Synonyms: A 64077; Abbott 64077
Research Areas:  

Inflammation/Immunology Cancer

Zileuton is a potent and selective inhibitor of 5-lipoxygenase with antiasthmatic properties.
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-14164A
CAS No.: 118569-21-4
Purity:  98.61%
Synonyms: A 64077 sodium; Abbott 64077 sodium
Target:  

Lipoxygenase

Research Areas:  

Inflammation/Immunology Cancer

Zileuton sodium (A 64077 sodium) is a potent and selective inhibitor of 5-lipoxygenase, exhibiting inflammatory activities.
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-N0551
CAS No.: 524-12-9
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibits the IKK Complex. Wedelolactone also inhibits 5-lipoxygenase (5-Lox) with an IC50 of 2.5 μM. Wedelolactone induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Wedelolactone can extract from Eclipta alba, and it can be used for the research of cancer .
loading...
    loading...
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-N0198
CAS No.: 500-38-9
Synonyms: NDGA
Nordihydroguaiaretic acid is a 5-lipoxygenase (5LOX) (IC50=8 μM) and tyrosine kinase inhibitor.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-108630
CAS No.: 142878-12-4
Purity:  99.31%
Target:  

Phospholipase

Research Areas:  

Others

U-73343, works as a protonophore, is an inactive analog of U-73122 and can be used as a negative control. U-73343 dose-dependently inhibits acid secretion irrespective of the stimulant. U-73122 is a phospholipase C (PLC) and 5-LO (5-lipoxygenase) inhibitor with an IC50 of 1-2.1 μM for PLC .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19807
CAS No.: 160807-49-8
Synonyms: Indirubin-3'-oxime
Target:  

GSK-3 CDK Lipoxygenase

Research Areas:  

Cancer

Indirubin-3'-monoxime is a potent GSK-3β inhibitor, and weakly inhibits 5-Lipoxygenase, with IC50s of 22 nM and 7.8-10 µM, respectively; Indirubin-3'-monoxime also shows inhibitory activities against CDK5/p25 and CDK1/cyclin B, with IC50s of 100 and 180 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N2513
CAS No.: 631-69-6
β-Boswellic acid is isolated from the gum resin of Boswellia serrata with anticancer, antioxidant activity, anti-inflammatory activity and anti-arthritic pain.β-Boswellic acid is an orally active nonreducing-type inhibitor of the 5-lipoxygenase (5-LO) product formation either interacting directly with the 5-LO or blocking its translocation. β-Boswellic acid inhibits the synthesis of DNA, RNA and protein in human leukemia HL-60 cells with IC50 values ranging from 0.6 to 7.1 μM. β-Boswellic acid is promising for research of diabetes, inflammatory and arthritic diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-110399
CAS No.: 34334-69-5
Purity:  99.26%
Cirsiliol is a potent and selective 5-lipoxygenase inhibitor and a competitive low affinity benzodiazepine receptor ligand.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-50714
CAS No.: 147030-01-1
Synonyms: MK-591 sodium
Target:  

FLAP Apoptosis

Research Areas:  

Inflammation/Immunology

Quiflapon sodium (MK-591 sodium) is a selective and specific 5-Lipoxygenase-activating protein (FLAP) inhibitor. Quiflapon sodium is an orally active Leukotriene biosynthesis inhibitor. Induces apoptosis.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15874
CAS No.: 936350-00-4
Purity:  99.50%
Synonyms: GSK2190915; AM-803
Research Areas:  

Inflammation/Immunology

Fiboflapon (GSK2190915; AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein (FLAP) inhibitor with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15874A
CAS No.: 1196070-26-4
Purity:  99.46%
Synonyms: GSK2190915 sodium salt; AM-803 sodium
Research Areas:  

Inflammation/Immunology

Fiboflapon sodium (GSK2190915; AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein (FLAP) inhibitor with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10037
CAS No.: 136668-42-3
Purity:  99.84%
Synonyms: MK-591
Target:  

FLAP Apoptosis

Research Areas:  

Inflammation/Immunology

Quiflapon (MK-591) is a selective and specific 5-lipoxygenase-activating protein (FLAP) inhibitor with an IC50 of 1.6 nM in a FLAP binding assay. Quiflapon is also a potent and orally active Leukotriene biosynthesis (LT) inhibitor, shows IC50 values of 3.1 and 6.1 nM in intact human and elicited rat PMNLs, respectively. Quiflapon induces cell apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1235
CAS No.: 546-88-3
Synonyms: N-Hydroxyacetamide
Acetohydroxamic acid is the inhibitor for bacterial and plant urease that can be used for chronic urinary tract infections. Acetohydroxamic acid selectively inhibits arachidonic acid 5-lipoxygenase that is useful in the research of asthma. Acetohydroxamic acid inhibits the formation of advanced glycation end products, and reduces oxidative stress and inflammatory responses. Acetohydroxamic acid exhibits antiviral activity against HIV .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0172R
CAS No.: 331-39-5
Caffeic acid (Standard) is the analytical standard of Caffeic acid. This product is intended for research and analytical applications. Caffeic acid is an inhibitor of both TRPV1 ion channel and 5-Lipoxygenase (5-LO).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1452
CAS No.: 156897-06-2
Synonyms: ML-3000
Target:  

COX Lipoxygenase Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Licofelone (ML-3000) is a dual COX/5-lipoxygenase (5-LOX) inhibitor (IC50=0.21/0.18 μM, respectively) for the treatment of osteoarthritis. Licofelone exerts anti-inflammatory and anti-proliferative effects. Licofelone induces apoptosis, and decreases the production of proinflammatory leukotrienes and prostaglandins .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128171
CAS No.: 724453-98-9
Purity:  99.67%
Target:  

FLAP Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

Diflapolin is a highly active dual 5-lipoxygenase-activating protein (FLAP)/soluble epoxide hydrolase (sEH) inhibitor with marked anti-inflammatory efficacy and high target selectivity. Diflapolin inhibits 5-LOX product formation in intact human monocytes and neutrophils with IC50s?of? 30 and 170?nM, respectively, and suppressed the activity of isolated sEH (IC50=20?nM) .
loading...
    loading...
Cat. No.: HY-122908
CAS No.: 2041075-86-7
Purity:  98.97%
Synonyms: AZD5718
Target:  

FLAP

Research Areas:  

Cardiovascular Disease

Atuliflapon (AZD5718) is an orally active inhibitor of FLAP (5?Lipoxygenase activating protein), with an IC50 of 2 nM. Atuliflapon is used in the study for coronary artery disease .
loading...
    loading...